Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol to Enhance Hydromorphone Analgesia
NCT02901275Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Dec 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dronabinol in pain (5 arms), sponsored by Johns Hopkins University. Primary endpoints: Mean Change From Baseline in Seconds to Withdraw Hand From Cold Pressor Laboratory Pain Task, Mean Peak Rating of 'Drug Effect' as Measured by the Visual Analog Rating Scale at 8 hours and 1 more. Started Dec 2016; status: completed.
02
Drugs
dronabinol
03
Conditions
pain
Beyond the preview
Go deeper on NCT02901275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901275.